Health & Fitness
Fri, March 1, 2013Thu, February 28, 2013Wed, February 27, 2013Tue, February 26, 2013Mon, February 25, 2013Sun, February 24, 2013Sat, February 23, 2013Fri, February 22, 2013Thu, February 21, 2013Wed, February 20, 2013Tue, February 19, 2013Mon, February 18, 2013Sun, February 17, 2013Fri, February 15, 2013Thu, February 14, 2013Wed, February 13, 2013Tue, February 12, 2013Mon, February 11, 2013Sun, February 10, 2013Fri, February 8, 2013Thu, February 7, 2013Vermillion to Report Results for Fourth Quarter and Full Year 2012 on Wednesday, February 20, 2013
Published in Health and Fitness on Tuesday, February 19th 2013 at 7:30 GMT by Market Wire
Vermillion to Report Results for Fourth Quarter and Full Year 2012 on... -- AUSTIN, Texas, Feb. 19, 2013 /PRNewswire/ --
AUSTIN, Texas, Feb. 19, 2013 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: [ VRML ]), a molecular diagnostics company focused on gynecologic cancers and vascular medicine, will hold a conference call on Wednesday, February 20, 2013, at 4:30 p.m. ET to discuss full results for its fourth quarter and year ended December 31, 2012.
While previously expecting to report only preliminary results on this date, the company recently received its annual 'true-up' of OVA1 sales from Quest Diagnostics ahead of schedule. This will allow for complete 2012 results to be issued in a press release prior to the call.
Vermillion's interim CEO Bruce A. Huebner will host the call, followed by a question and answer period.
Date: Wednesday, February 20, 2013
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
Dial-In Number: 1-800-909-4761
International: 1-212-231-2934
Conference ID#: 21648726
Webcast: [ http://edge.media-server.com/m/p/e247e2q2/lan/en ]
The conference call will be webcast live and available for replay via the investor section of the company's website at [ www.vermillion.com ].
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.
A replay of the call will be available approximately two hours after the call through March 6, 2013.
Toll-free replay number: 1-800-633-8284
International replay number: 1-402-977-9140
Replay pin number: 21648726
About Vermillion
Vermillion, Inc. (NASDAQ: [ VRML ]) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, vascular medicine and women's health. Additional information about Vermillion can be found at [ www.vermillion.com ].
Investor Relations Contact:
Liolios Group, Inc.
Ron Both
Tel 1-949-574-3860
[ vrml@liolios.com ]
SOURCE Vermillion, Inc.
RELATED LINKS
[ http://www.vermillion.com ]
